iberdomide
Drug timelines are a Plus or Pro feature.
25 regulatory and trial events tracked for iberdomide, covering 2017-10-25 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30) [Phase 1]